Compare FOLD & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | KLIC |
|---|---|---|
| Founded | 2002 | 1951 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.4B |
| IPO Year | 2007 | N/A |
| Metric | FOLD | KLIC |
|---|---|---|
| Price | $11.00 | $45.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $30.29 | ★ $46.67 |
| AVG Volume (30 Days) | ★ 5.3M | 775.2K |
| Earning Date | 11-04-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 1.75% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $598,704,000.00 | ★ $654,081,000.00 |
| Revenue This Year | $21.49 | $20.77 |
| Revenue Next Year | $18.25 | $8.23 |
| P/E Ratio | ★ N/A | $11,692.50 |
| Revenue Growth | ★ 21.28 | N/A |
| 52 Week Low | $5.51 | $26.63 |
| 52 Week High | $11.14 | $52.08 |
| Indicator | FOLD | KLIC |
|---|---|---|
| Relative Strength Index (RSI) | 79.64 | 55.52 |
| Support Level | $9.73 | $47.50 |
| Resistance Level | $11.14 | $49.69 |
| Average True Range (ATR) | 0.36 | 1.65 |
| MACD | 0.09 | -0.17 |
| Stochastic Oscillator | 91.14 | 25.00 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Kulicke & Soffa Industries Inc. is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments, which include Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.